Dual-targeting CAR-NK cells targeting mesothelin (MSLN) and MUC1

CAR-NK cells targeting mesothelin and MUC1 · Beijing Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dual-targeting CAR-NK cells targeting mesothelin (MSLN) and MUC1, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma [Phase 1, Phase 2]

See pricing